An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AMLDyantha I. van der Lee, Marieke Griffioen, Georgia Koutsoumpli et al.|Cancers|2021Cited by 14
High-affinity CD8 variants enhance the sensitivity of pMHCI antigen recognition via low-affinity TCRsLea Knežević, Linda Wooldridge, John S. Bridgeman et al.|Journal of Biological Chemistry|2023Cited by 9